EPO and anemia (phenotype): As NF-κB is one of the central transcription factors to initiate and perpetuate inflammation, its negative effect on EPO expression in inflammatory conditions may contribute to the pathogenesis of the anemia of chronic disease (ACD), which frequently occurs in patients suffering from inflammatory diseases thereby negatively impacting on organ function and quality of life [9].